Aptagen, LLC
G12msi (ID# 8073)
DNA
GPC3
Protein
0.17 nM (reported value)
4.5 g/L glucose, 5 mM MgCl2, 0.1 mg/mL yeast tRNA, and 1 mg/mL
bovine serum albumin
25°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
In the sequence: D - Gemcitabine
5'-dGpdTpdGpdApdApdTpdTpdGpdCpdGpdTpdTpdGpdApdApdTpdTpdApdTpdGpdTpdDpdDpdDpdTpdTpdCpdApdGpdTpdCpdApdTpdCpdApdCp dTp -3'
37
11399.4
358601.769336
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Park, J. Y., Chae, J. R., Cho, Y. L., Kim, Y., Lee, D., Lee, J. K., & Kang, W. J. (2020). Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer. Pharmaceutics, 12(10), 985. doi:10.3390/pharmaceutics12100985
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.